Histiocytoma, Malignant Fibrous
Showing 1 - 25 of 4,243
Undifferentiated Pleomorphic Sarcoma Trial in Iowa City (Palbociclib, Pembrolizumab)
Not yet recruiting
- Undifferentiated Pleomorphic Sarcoma
-
Iowa City, IowaUniversity of Iowa Hospitals & Clinics
Nov 1, 2023
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,
Recruiting
- Soft Tissue Sarcoma Adult
- +2 more
-
Aarhus, Denmark
- +3 more
Jul 23, 2023
Soft Tissue Sarcoma Adult, Undifferentiated Pleomorphic Sarcoma, Epithelioid Sarcoma Trial in Bordeaux (Trabectedin)
Recruiting
- Soft Tissue Sarcoma Adult
- +6 more
-
Bordeaux, FranceInstitut Bergonie
Feb 1, 2022
Undifferentiated Pleomorphic Sarcoma Trial in San Francisco (ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound
Recruiting
- Undifferentiated Pleomorphic Sarcoma
- ExAblate 2000/2100 Magnetic Resonance-guided Focused Ultrasound (MRgFUS)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 28, 2022
Metastatic Extraskeletal Myxoid Chondrosarcoma, Metastatic Leiomyosarcoma, Metastatic Liposarcoma Trial (procedure, drug,
Not yet recruiting
- Metastatic Extraskeletal Myxoid Chondrosarcoma
- +3 more
- Biopsy
- +6 more
- (no location specified)
Apr 25, 2023
Osteosarcoma, Bone Tumor, Bone Sarcoma Trial
Not yet recruiting
- Osteosarcoma
- +25 more
- (no location specified)
Aug 24, 2022
Locally Advanced Undifferentiated Pleomorphic Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma, Recurrent
Recruiting
- Locally Advanced Undifferentiated Pleomorphic Sarcoma
- +3 more
- Sintilimab
-
Houston, TexasM D Anderson Cancer Center
Jul 31, 2022
Metastatic Leiomyosarcoma, Metastatic Synovial Sarcoma, Metastatic Undifferentiated Pleomorphic Sarcoma Trial in Seattle
Recruiting
- Metastatic Leiomyosarcoma
- +17 more
- Itacitinib
- Laboratory Biomarker Analysis
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 13, 2022
Sarcoma, Soft Tissue Trial in Beijing (Recombinant anti-PD-1 humanized mAb injection)
Not yet recruiting
- Sarcoma, Soft Tissue
- Recombinant anti-PD-1 humanized monoclonal antibody injection
-
Beijing, Beijing, ChinaBeijing Jishuitan Hospital
Dec 31, 2021
Sarcoma, Myxofibrosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in United States (Isolated Limb Infusion, Pembrolizumab,
Recruiting
- Sarcoma
- +3 more
- Isolated Limb Infusion
- +2 more
-
Basking Ridge, New Jersey
- +6 more
Nov 21, 2022
Leiomyosarcoma, Malignant Peripheral Nerve Sheath Tumor, Myxofibrosarcoma Trial in Los Angeles (procedure, biological,
Recruiting
- Leiomyosarcoma
- +29 more
- Definitive Surgical Resection
- +3 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 26, 2022
Advanced Soft Tissue Sarcoma, Locally Advanced Angiosarcoma, Locally Advanced Leiomyosarcoma Trial in Portland (Doxorubicin
Active, not recruiting
- Advanced Soft Tissue Sarcoma
- +26 more
- Doxorubicin Hydrochloride
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jan 6, 2023
Dedifferentiated Liposarcoma, Recurrent Dedifferentiated Liposarcoma, Recurrent Undifferentiated Pleomorphic Sarcoma Trial in
Active, not recruiting
- Dedifferentiated Liposarcoma
- +5 more
- Ipilimumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Bone Sarcoma, Osteosarcoma, Ewing Sarcoma Trial in France (Treatment by Regorafenib, Treatment by Placebo)
Recruiting
- Bone Sarcoma
- +6 more
- Treatment by Regorafenib
- Treatment by Placebo
-
Besançon, France
- +15 more
Aug 18, 2022
Soft Tissue Sarcoma, Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma Trial in Providence (Gemcitabine, 9-ING-41,
Withdrawn
- Soft Tissue Sarcoma
- +12 more
- Gemcitabine
- +2 more
-
Providence, Rhode Island
- +1 more
Nov 30, 2021
Sarcoma Trial in London (Pembrolizumab, Gemcitabine)
Active, not recruiting
- Sarcoma
-
London, United KingdomRoyal Marsden
Jun 29, 2021
Solid Tumor, Triple-negative Breast Cancer, Gastric Adenocarcinoma Trial in Houston, Chuo-Ku (LY3435151, Pembrolizumab)
Terminated
- Solid Tumor
- +8 more
-
Houston, Texas
- +1 more
Aug 4, 2021
Adult Alveolar Soft Part Sarcoma, Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor Trial in Portland, Seattle
Completed
- Adult Alveolar Soft Part Sarcoma
- +18 more
- Gemcitabine
- +5 more
-
Portland, Oregon
- +1 more
Sep 23, 2021
Bone Sarcoma, Dedifferentiated Chondrosarcoma, Giant Cell Tumor of Bone Trial in Houston (biological, drug, other)
Recruiting
- Bone Sarcoma
- +15 more
- Aldesleukin
- +8 more
-
Houston, TexasM D Anderson Cancer Center
Aug 3, 2022
Sarcoma, Alveolar Soft Part Sarcoma, Clear Cell Sarcoma Trial in Warsaw (Hypofractionated radiotherapy, Hyperthermia)
Active, not recruiting
- Sarcoma
- +10 more
- Hypofractionated radiotherapy
- Hyperthermia
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 27, 2021
Sarcoma, Fibrosarcoma, Leiomyosarcoma Trial in Warsaw (Sequential chemo - 3 courses of AI, Hypofractionated radiotherapy)
Unknown status
- Sarcoma
- +16 more
- Sequential chemotherapy - 3 courses of AI
- Hypofractionated radiotherapy
-
Warsaw, Mazovian, PolandMaria Sklodowska-Curie Institute - Oncology Center
Jan 19, 2021
Angiomatoid Fibrous Histiocytoma:Single Institution Case-series
Completed
- Angiomatoid Fibrous Histiocytoma
-
Bologna, ItalyIRCC Rizzoli Orthopedic Institute
Feb 11, 2020
Melanoma (Excluding Uveal Melanoma), Cervical Carcinoma, Pancreatic Carcinoma Trial in United States (XmAb®23104, Yervoy®
Recruiting
- Melanoma (Excluding Uveal Melanoma)
- +15 more
- XmAb®23104
- Yervoy® (ipilimumab)
-
San Diego, California
- +15 more
Sep 20, 2021